These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 19656069

  • 1. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J, Kossou H, Fayomi B, Ayemonna P, Fievet N, Massougbodji A, Cot M.
    J Infect Dis; 2009 Sep 15; 200(6):991-1001. PubMed ID: 19656069
    [Abstract] [Full Text] [Related]

  • 2. Mefloquine for preventing malaria in pregnant women.
    González R, Pons-Duran C, Piqueras M, Aponte JJ, Ter Kuile FO, Menéndez C.
    Cochrane Database Syst Rev; 2018 Mar 21; 3(3):CD011444. PubMed ID: 29561063
    [Abstract] [Full Text] [Related]

  • 3. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
    Clerk CA, Bruce J, Affipunguh PK, Mensah N, Hodgson A, Greenwood B, Chandramohan D.
    J Infect Dis; 2008 Oct 15; 198(8):1202-11. PubMed ID: 18752443
    [Abstract] [Full Text] [Related]

  • 4. Mefloquine for preventing malaria in pregnant women.
    González R, Pons-Duran C, Piqueras M, Aponte JJ, Ter Kuile FO, Menéndez C.
    Cochrane Database Syst Rev; 2018 Nov 14; 11(11):CD011444. PubMed ID: 30480761
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, Steketee RW, Hamel M.
    J Infect Dis; 2006 Aug 01; 194(3):286-93. PubMed ID: 16826475
    [Abstract] [Full Text] [Related]

  • 6. Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
    Rupérez M, González R, Mombo-Ngoma G, Kabanywanyi AM, Sevene E, Ouédraogo S, Kakolwa MA, Vala A, Accrombessi M, Briand V, Aponte JJ, Manego Zoleko R, Adegnika AA, Cot M, Kremsner PG, Massougbodji A, Abdulla S, Ramharter M, Macete E, Menéndez C.
    PLoS Med; 2016 Feb 01; 13(2):e1001964. PubMed ID: 26905278
    [Abstract] [Full Text] [Related]

  • 7. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S, Coulibaly SO, Ouattara FT, D'Alessandro U.
    Trop Med Int Health; 2009 Feb 01; 14(2):174-82. PubMed ID: 19171009
    [Abstract] [Full Text] [Related]

  • 8. Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.
    Briand V, Escolano S, Journot V, Massougbodji A, Cot M, Tubert-Bitter P.
    Am J Trop Med Hyg; 2015 Aug 01; 93(2):300-4. PubMed ID: 26055735
    [Abstract] [Full Text] [Related]

  • 9. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ.
    J Infect Dis; 2007 Dec 01; 196(11):1585-94. PubMed ID: 18008241
    [Abstract] [Full Text] [Related]

  • 10. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique.
    Challis K, Osman NB, Cotiro M, Nordahl G, Dgedge M, Bergström S.
    Trop Med Int Health; 2004 Oct 01; 9(10):1066-73. PubMed ID: 15482398
    [Abstract] [Full Text] [Related]

  • 11. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae.
    Mbaye A, Richardson K, Balajo B, Dunyo S, Shulman C, Milligan P, Greenwood B, Walraven G.
    Trop Med Int Health; 2006 Jul 01; 11(7):992-1002. PubMed ID: 16827700
    [Abstract] [Full Text] [Related]

  • 12. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
    Gies S, Coulibaly SO, Ouattara FT, Ky C, Brabin BJ, D'Alessandro U.
    Malar J; 2008 Sep 18; 7():180. PubMed ID: 18801158
    [Abstract] [Full Text] [Related]

  • 13. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
    Diakite OS, Kayentao K, Traoré BT, Djimde A, Traoré B, Diallo M, Ongoiba A, Doumtabé D, Doumbo S, Traoré MS, Dara A, Guindo O, Karim DM, Coulibaly S, Bougoudogo F, Ter Kuile FO, Danis M, Doumbo OK.
    Clin Infect Dis; 2011 Aug 01; 53(3):215-23. PubMed ID: 21765069
    [Abstract] [Full Text] [Related]

  • 14. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB, Cotte AH, Konaté A, Moran AC, Asamoa K, Bougouma EC, Diarra A, Ouédraogo A, Parise ME, Newman RD.
    Am J Trop Med Hyg; 2006 Aug 01; 75(2):205-11. PubMed ID: 16896120
    [Abstract] [Full Text] [Related]

  • 15. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali.
    Kayentao K, Kodio M, Newman RD, Maiga H, Doumtabe D, Ongoiba A, Coulibaly D, Keita AS, Maiga B, Mungai M, Parise ME, Doumbo O.
    J Infect Dis; 2005 Jan 01; 191(1):109-16. PubMed ID: 15593011
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial.
    Anvikar AR, Kuepfer I, Mishra V, Bruce J, Arya T, Mishra DR, Mohanty S, Mohanty R, Srivastava B, Sharma S, Mishra N, Greenwood B, Chandramohan D, Valecha N.
    Malar J; 2018 Jul 04; 17(1):246. PubMed ID: 29973212
    [Abstract] [Full Text] [Related]

  • 17. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, Mosha FW, Greenwood B, Chandramohan D.
    Lancet; 2009 Oct 31; 374(9700):1521-32. PubMed ID: 19765815
    [Abstract] [Full Text] [Related]

  • 18. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
    Gill CJ, Macleod WB, Mwanakasale V, Chalwe V, Mwananyanda L, Champo D, Mukwamataba D, Chilengi R, Thea DM, Hamer DH.
    J Infect Dis; 2007 Dec 01; 196(11):1577-84. PubMed ID: 18008240
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of intermittent preventive treatment versus chloroquine prophylaxis to prevent malaria during pregnancy in Benin.
    Briand V, Denoeud L, Massougbodji A, Cot M.
    J Infect Dis; 2008 Aug 15; 198(4):594-601. PubMed ID: 18598190
    [Abstract] [Full Text] [Related]

  • 20. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
    Sicuri E, Fernandes S, Macete E, González R, Mombo-Ngoma G, Massougbodgi A, Abdulla S, Kuwawenaruwa A, Katana A, Desai M, Cot M, Ramharter M, Kremsner P, Slustker L, Aponte J, Hanson K, Menéndez C.
    PLoS One; 2015 Aug 15; 10(4):e0125072. PubMed ID: 25915616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.